HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-JUN-13 4L7P TITLE HUMAN ARTD3 (PARP3) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TITLE 2 ME0395 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC PARP DOMAIN; COMPND 5 SYNONYM: PARP-3, HPARP-3, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN- COMPND 6 LIKE 3, ARTD3, IRT1, NAD(+) ADP-RIBOSYLTRANSFERASE 3, ADPRT-3, COMPND 7 POLY[ADP-RIBOSE] SYNTHASE 3, PADPRT-3; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADPRT3, ADPRTL3, PARP3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4 KEYWDS DIPHTHERIA TOXIN LIKE ADP-RIBOSE TRASNFERASE, TRANSFERASE, ADP- KEYWDS 2 RIBOSYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,A.E.G.LINDGREN,T.EKBLAD,S.SPJUT, AUTHOR 2 C.D.ANDERSSON,J.WEIGELT,A.LINUSSON,M.ELOFSSON,H.SCHULER REVDAT 2 20-SEP-23 4L7P 1 REMARK SEQADV REVDAT 1 19-FEB-14 4L7P 0 JRNL AUTH A.E.LINDGREN,T.KARLBERG,T.EKBLAD,S.SPJUT,A.G.THORSELL, JRNL AUTH 2 C.D.ANDERSSON,T.T.NHAN,V.HELLSTEN,J.WEIGELT,A.LINUSSON, JRNL AUTH 3 H.SCHULER,M.ELOFSSON JRNL TITL CHEMICAL PROBES TO STUDY ADP-RIBOSYLATION: SYNTHESIS AND JRNL TITL 2 BIOCHEMICAL EVALUATION OF INHIBITORS OF THE HUMAN JRNL TITL 3 ADP-RIBOSYLTRANSFERASE ARTD3/PARP3. JRNL REF J.MED.CHEM. V. 56 9556 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24188023 JRNL DOI 10.1021/JM401394U REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 15206 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1216 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.46 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2745 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1867 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2525 REMARK 3 BIN R VALUE (WORKING SET) : 0.1829 REMARK 3 BIN FREE R VALUE : 0.2291 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 220 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2723 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.32700 REMARK 3 B22 (A**2) : 9.07310 REMARK 3 B33 (A**2) : -4.74620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.33310 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.251 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.350 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2810 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3807 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1297 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 403 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2810 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 358 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3065 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.30 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.84 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|177 - A|532 } REMARK 3 ORIGIN FOR THE GROUP (A): 2.2220 -0.5828 22.8490 REMARK 3 T TENSOR REMARK 3 T11: -0.0873 T22: -0.0978 REMARK 3 T33: -0.0374 T12: -0.0187 REMARK 3 T13: 0.0149 T23: -0.0035 REMARK 3 L TENSOR REMARK 3 L11: 0.6632 L22: 1.1064 REMARK 3 L33: 1.0443 L12: -0.1790 REMARK 3 L13: 0.0976 L23: -0.3052 REMARK 3 S TENSOR REMARK 3 S11: 0.0452 S12: -0.0825 S13: -0.0143 REMARK 3 S21: 0.1086 S22: 0.0188 S23: 0.1345 REMARK 3 S31: -0.0072 S32: -0.0330 S33: -0.0640 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4L7P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1000080285. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15221 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : 0.10600 REMARK 200 FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.60300 REMARK 200 R SYM FOR SHELL (I) : 0.52300 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4GV4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9M DL-MALIC ACID, 0.1M BIS-TRIS REMARK 280 -PROPANE , PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.26750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMERIC REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 176 REMARK 465 GLY A 242 REMARK 465 PRO A 243 REMARK 465 THR A 244 REMARK 465 ASP A 245 REMARK 465 GLY A 246 REMARK 465 GLY A 247 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 191 CD CE NZ REMARK 470 GLU A 251 CD OE1 OE2 REMARK 470 HIS A 267 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 350 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 351 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 375 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 350 -60.17 -93.41 REMARK 500 HIS A 373 13.92 -143.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M95 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L6Z RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1168. REMARK 900 RELATED ID: 4L70 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ME0352. REMARK 900 RELATED ID: 4L7L RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ME0368. REMARK 900 RELATED ID: 4L7N RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1541. REMARK 900 RELATED ID: 4L7O RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1542. REMARK 900 RELATED ID: 4L7R RELATED DB: PDB REMARK 900 RELATED ID: 4L7U RELATED DB: PDB DBREF 4L7P A 178 532 UNP Q9Y6F1 PARP3_HUMAN 178 532 SEQADV 4L7P SER A 176 UNP Q9Y6F1 EXPRESSION TAG SEQADV 4L7P MET A 177 UNP Q9Y6F1 EXPRESSION TAG SEQRES 1 A 357 SER MET LYS ARG VAL GLN PRO CYS SER LEU ASP PRO ALA SEQRES 2 A 357 THR GLN LYS LEU ILE THR ASN ILE PHE SER LYS GLU MET SEQRES 3 A 357 PHE LYS ASN THR MET ALA LEU MET ASP LEU ASP VAL LYS SEQRES 4 A 357 LYS MET PRO LEU GLY LYS LEU SER LYS GLN GLN ILE ALA SEQRES 5 A 357 ARG GLY PHE GLU ALA LEU GLU ALA LEU GLU GLU ALA LEU SEQRES 6 A 357 LYS GLY PRO THR ASP GLY GLY GLN SER LEU GLU GLU LEU SEQRES 7 A 357 SER SER HIS PHE TYR THR VAL ILE PRO HIS ASN PHE GLY SEQRES 8 A 357 HIS SER GLN PRO PRO PRO ILE ASN SER PRO GLU LEU LEU SEQRES 9 A 357 GLN ALA LYS LYS ASP MET LEU LEU VAL LEU ALA ASP ILE SEQRES 10 A 357 GLU LEU ALA GLN ALA LEU GLN ALA VAL SER GLU GLN GLU SEQRES 11 A 357 LYS THR VAL GLU GLU VAL PRO HIS PRO LEU ASP ARG ASP SEQRES 12 A 357 TYR GLN LEU LEU LYS CYS GLN LEU GLN LEU LEU ASP SER SEQRES 13 A 357 GLY ALA PRO GLU TYR LYS VAL ILE GLN THR TYR LEU GLU SEQRES 14 A 357 GLN THR GLY SER ASN HIS ARG CYS PRO THR LEU GLN HIS SEQRES 15 A 357 ILE TRP LYS VAL ASN GLN GLU GLY GLU GLU ASP ARG PHE SEQRES 16 A 357 GLN ALA HIS SER LYS LEU GLY ASN ARG LYS LEU LEU TRP SEQRES 17 A 357 HIS GLY THR ASN MET ALA VAL VAL ALA ALA ILE LEU THR SEQRES 18 A 357 SER GLY LEU ARG ILE MET PRO HIS SER GLY GLY ARG VAL SEQRES 19 A 357 GLY LYS GLY ILE TYR PHE ALA SER GLU ASN SER LYS SER SEQRES 20 A 357 ALA GLY TYR VAL ILE GLY MET LYS CYS GLY ALA HIS HIS SEQRES 21 A 357 VAL GLY TYR MET PHE LEU GLY GLU VAL ALA LEU GLY ARG SEQRES 22 A 357 GLU HIS HIS ILE ASN THR ASP ASN PRO SER LEU LYS SER SEQRES 23 A 357 PRO PRO PRO GLY PHE ASP SER VAL ILE ALA ARG GLY HIS SEQRES 24 A 357 THR GLU PRO ASP PRO THR GLN ASP THR GLU LEU GLU LEU SEQRES 25 A 357 ASP GLY GLN GLN VAL VAL VAL PRO GLN GLY GLN PRO VAL SEQRES 26 A 357 PRO CYS PRO GLU PHE SER SER SER THR PHE SER GLN SER SEQRES 27 A 357 GLU TYR LEU ILE TYR GLN GLU SER GLN CYS ARG LEU ARG SEQRES 28 A 357 TYR LEU LEU GLU VAL HIS HET M95 A 601 26 HETNAM M95 (2E)-N-[(2S)-1-HYDROXY-3-PHENYLPROPAN-2-YL]-3-(4-OXO-1, HETNAM 2 M95 4-DIHYDROQUINAZOLIN-2-YL)PROP-2-ENAMIDE FORMUL 2 M95 C20 H19 N3 O3 FORMUL 3 HOH *46(H2 O) HELIX 1 1 ASP A 186 PHE A 197 1 12 HELIX 2 2 SER A 198 MET A 209 1 12 HELIX 3 3 SER A 222 LYS A 241 1 20 HELIX 4 4 SER A 249 ILE A 261 1 13 HELIX 5 5 SER A 275 GLN A 299 1 25 HELIX 6 6 SER A 302 THR A 307 1 6 HELIX 7 7 HIS A 313 LEU A 322 1 10 HELIX 8 8 ALA A 333 GLY A 347 1 15 HELIX 9 9 GLY A 365 GLN A 371 1 7 HELIX 10 10 ALA A 372 SER A 374 5 3 HELIX 11 11 ASN A 387 ALA A 389 5 3 HELIX 12 12 VAL A 390 GLY A 398 1 9 HELIX 13 13 GLU A 418 GLY A 424 1 7 HELIX 14 14 PRO A 479 ASP A 482 5 4 HELIX 15 15 PRO A 503 SER A 506 5 4 HELIX 16 16 GLN A 519 SER A 521 5 3 SHEET 1 A 2 ARG A 179 VAL A 180 0 SHEET 2 A 2 GLU A 310 VAL A 311 1 O VAL A 311 N ARG A 179 SHEET 1 B 5 CYS A 324 LEU A 328 0 SHEET 2 B 5 THR A 354 GLN A 363 -1 O LYS A 360 N GLN A 327 SHEET 3 B 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 B 5 HIS A 434 ALA A 445 -1 N GLU A 443 O ARG A 524 SHEET 5 B 5 ARG A 379 GLY A 385 -1 N LEU A 382 O GLY A 442 SHEET 1 C 5 CYS A 324 LEU A 328 0 SHEET 2 C 5 THR A 354 GLN A 363 -1 O LYS A 360 N GLN A 327 SHEET 3 C 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 C 5 HIS A 434 ALA A 445 -1 N GLU A 443 O ARG A 524 SHEET 5 C 5 MET A 429 CYS A 431 -1 N CYS A 431 O HIS A 434 SHEET 1 D 4 ILE A 413 PHE A 415 0 SHEET 2 D 4 GLU A 514 ILE A 517 -1 O TYR A 515 N PHE A 415 SHEET 3 D 4 SER A 468 ALA A 471 -1 N VAL A 469 O LEU A 516 SHEET 4 D 4 GLU A 449 ILE A 452 1 N HIS A 450 O ILE A 470 SHEET 1 E 2 THR A 475 PRO A 477 0 SHEET 2 E 2 PRO A 499 PRO A 501 -1 O VAL A 500 N GLU A 476 SHEET 1 F 2 THR A 483 LEU A 487 0 SHEET 2 F 2 GLN A 490 VAL A 494 -1 O GLN A 490 N LEU A 487 SITE 1 AC1 9 HIS A 384 GLY A 385 THR A 386 TYR A 414 SITE 2 AC1 9 PHE A 415 SER A 422 TYR A 425 ILE A 427 SITE 3 AC1 9 GLU A 514 CRYST1 56.876 56.535 58.622 90.00 114.26 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017582 0.000000 0.007924 0.00000 SCALE2 0.000000 0.017688 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018711 0.00000